{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:54:29Z","timestamp":1793660069879,"version":"4.5.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005192","name":"California HIV\/AIDS Research Program","doi-asserted-by":"publisher","award":["PR15-SD-021"],"award-info":[{"award-number":["PR15-SD-021"]}],"id":[{"id":"10.13039\/100005192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005192","name":"California HIV\/AIDS Research Program","doi-asserted-by":"publisher","award":["H22BD4432S"],"award-info":[{"award-number":["H22BD4432S"]}],"id":[{"id":"10.13039\/100005192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5T32DA031098"],"award-info":[{"award-number":["5T32DA031098"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5T32DA031098"],"award-info":[{"award-number":["5T32DA031098"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["L30 DA056940"],"award-info":[{"award-number":["L30 DA056940"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA051324"],"award-info":[{"award-number":["K23DA051324"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG084417"],"award-info":[{"award-number":["F31AG084417"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Despite known benefits of Motivational Interviewing (MI) for medication adherence, its effectiveness in supporting pre-exposure prophylaxis (PrEP) adherence among transgender and nonbinary (TGNB) populations remains underexplored. This study applies mixed-methods analysis to understand PrEP adherence among TGNB individuals who received a daily individualized text-message intervention and phone-based MI for non-adherence to PrEP. Individuals who did not respond to three consecutive messages were identified as potential MI recipients. We had three objectives: (1) examine psychosocial differences between participants who needed MI (MI Indicated group; n\u2009=\u200981) versus those who did not (MI Not Indicated group; n\u2009=\u200948), (2) assess whether Health Belief Model (HBM) constructs were associated with PrEP adherence, and (3) identify adherence barriers and facilitators. This secondary analysis builds on primary intervention outcomes published in Morris et al. (J Acquire Immune Defic Syndr 91:453\u2013459, 2022). We conducted multivariable linear regression on psychosocial measures and PrEP adherence, and inductive qualitative analysis on a subset of participants who completed at least one MI session (n\u2009=\u200960). Results were deductively mapped onto HBM constructs. Significant differences emerged between MI groups in HBM constructs, with the MI Indicated group reporting higher perceived HIV risk, stress, depressive symptoms, and poorer coping and self-efficacy. Findings highlight the need for personalized interventions to support PrEP adherence, mental health, and HIV risk perception among TGNB individuals. Future adherence interventions may benefit from assessing and addressing HBM constructs. To support the Ending the HIV Epidemic initiative, it is critical to enhance access to facilitators and mitigate barriers to PrEP adherence for this population.<\/jats:p>","DOI":"10.1007\/s10461-025-04810-y","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:26:42Z","timestamp":1752226002000},"page":"3687-3702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Barriers and Facilitators to PrEP Adherence among Transgender and Non-binary Individuals: A Mixed-Methods Analysis of Psychosocial Factors and Health Belief Model Constructs"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7632-4464","authenticated-orcid":false,"given":"D.","family":"Paltin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Narez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gouaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beckwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"4810_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). 2022. https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html#:~:text=PrEP%20is%20highly%20effective%20for,use%20by%20at%20least%2074%25."},{"issue":"12","key":"4810_CR2","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019Reilly KR, Koechlin FM, Grant RM. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973\u201383.","journal-title":"AIDS"},{"issue":"27","key":"4810_CR3","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Glidden DV. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Eng J Med. 2010;363(27):2587\u201399.","journal-title":"New Eng J Med"},{"issue":"12","key":"4810_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260063","volume":"16","author":"SE Stutterheim","year":"2021","unstructured":"Stutterheim SE, Pryor JB, Bos AER, Hoogendijk R, Muris P, Schaalma HP. The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis. PLoS ONE. 2021;16(12): e0260063.","journal-title":"PLoS ONE"},{"issue":"5","key":"4810_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1089\/trgh.2020.0141","volume":"7","author":"BO Olakunde","year":"2022","unstructured":"Olakunde BO, Pharr JR, Vu L, Hunt J, Adam MB, Barnett A, Nkyekyer A. Nonuptake of HIV testing among transgender populations in the United States: results from the 2015 U.S. Transgender Survey. Transgender Health. 2022;7(5):430\u20139.","journal-title":"Transgender Health"},{"issue":"Suppl 3","key":"4810_CR6","doi-asserted-by":"publisher","first-page":"S226","DOI":"10.1097\/QAI.0000000000001090","volume":"72","author":"RM Grant","year":"2016","unstructured":"Grant RM, Sevelius JM, Chung C, Liu A. Transgender women in clinical trials of pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S226\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4810_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/QAI.0000000000001839","volume":"79","author":"EM Jalil","year":"2018","unstructured":"Jalil EM, Wilson EC, Luz PM, Veloso VG, McFarland W, Grinsztejn B. Awareness, willingness, and PrEP eligibility among transgender women in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2018;79(4):445\u201352.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4810_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s10461-020-03050-6","volume":"25","author":"L Yan","year":"2021","unstructured":"Yan L, Zhang B, Pan S, Wu D, Chu J, Tang W. Awareness and willingness to use HIV pre-exposure prophylaxis (PrEP) among trans women in China: a community-based survey. AIDS Behav. 2021;25(3):866\u201374.","journal-title":"AIDS Behav"},{"issue":"8","key":"4810_CR9","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s10461-023-03983-8","volume":"27","author":"K Bruxvoort","year":"2023","unstructured":"Bruxvoort K, Killelea A, Koester KA, Jain JP, Madera N, Deutsch MB, Sevelius JM. Understanding barriers and facilitators of pre-exposure prophylaxis (PrEP) among transgender and gender diverse adults in an integrated health care system. AIDS Behav. 2023;27(8):2579\u201391.","journal-title":"AIDS Behav"},{"issue":"7","key":"4810_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s10461-015-1182-z","volume":"20","author":"LM Kuhns","year":"2016","unstructured":"Kuhns LM, Reisner SL, Pachankis JE, Garofalo R, Mimiaga MJ. Correlates of PrEP indication in a multi-site cohort of young HIV-uninfected transgender women. AIDS Behav. 2016;20(7):1470\u20137.","journal-title":"AIDS Behav"},{"key":"4810_CR11","doi-asserted-by":"publisher","first-page":"1150370","DOI":"10.3389\/frph.2023.1150370","volume":"5","author":"A Rodriguez","year":"2024","unstructured":"Rodriguez A, Johnson J, Abel J, Morgan E. Awareness and utilization of pre-exposure prophylaxis and HIV prevention services among transgender and non-binary adolescent and young adults. Front Reproduct Health. 2024;5:1150370.","journal-title":"Front Reproduct Health"},{"issue":"7","key":"4810_CR12","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10461-021-03159-2","volume":"25","author":"A Ogunbajo","year":"2021","unstructured":"Ogunbajo A, Storholm ED, Ober AJ, Bogart LM, Reback CJ, Flynn R, Mimiaga MJ. Multilevel barriers to HIV PrEP uptake and adherence among Black and Hispanic\/Latinx transgender women in Southern California. AIDS Behav. 2021;25(7):2301\u201315.","journal-title":"AIDS Behav"},{"issue":"1","key":"4810_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/trgh.2019.0027","volume":"4","author":"KJ Horvath","year":"2019","unstructured":"Horvath KJ, Todd K, Arayasirikul S, Wilson EC, Lippman SA. Underutilization of pre-exposure prophylaxis services among transgender and nonbinary youth: findings from Project Moxie and TechStep. Transgender Health. 2019;4(1):217\u201321.","journal-title":"Transgender Health"},{"issue":"7","key":"4810_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10461-018-2376-y","volume":"23","author":"SA Golub","year":"2019","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger C. Predictors of PrEP uptake among patients with equivalent access. AIDS Behav. 2019;23(7):1917\u201324.","journal-title":"AIDS Behav"},{"issue":"4","key":"4810_CR15","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","volume":"50","author":"R Muhumuza","year":"2021","unstructured":"Muhumuza R, Ssempijja V, Musoke L, Sibanda EL, Napierala M, Mugo N, Celum C. Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021;50(4):1729\u201342.","journal-title":"Arch Sex Behav"},{"issue":"2","key":"4810_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055487","volume":"12","author":"PB Carneiro","year":"2022","unstructured":"Carneiro PB, Nugent RM, Mathes BM, Glick SN, Golden MR. Demographic, clinical guideline criteria, Medicaid expansion and state of residency: a multilevel analysis of PrEP use on a large US sample. BMJ Open. 2022;12(2): e055487.","journal-title":"BMJ Open"},{"issue":"2","key":"4810_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172354","volume":"12","author":"T Arnold","year":"2017","unstructured":"Arnold T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer AG, Bologna ES, Beauchamps L, Nunn A. Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in Mississippi. PLoS ONE. 2017;12(2): e0172354.","journal-title":"PLoS ONE"},{"issue":"4","key":"4810_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10461-021-03482-8","volume":"26","author":"J Downing","year":"2022","unstructured":"Downing J, Yee K, Sevelius JM. PrEP use and adherence among transgender patients. AIDS Behav. 2022;26(4):1251\u20139.","journal-title":"AIDS Behav"},{"issue":"6","key":"4810_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267780","volume":"17","author":"M Cespedes","year":"2022","unstructured":"Cespedes M, Katz M, Andrasik M, et al. Proactive strategies to optimize engagement of Black, Hispanic\/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP). PLoS ONE. 2022;17(6): e0267780.","journal-title":"PLoS ONE"},{"issue":"1","key":"4810_CR20","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/QAI.0000000000002808","volume":"88","author":"JM Sevelius","year":"2021","unstructured":"Sevelius JM, Keatley J, Calma N, Arnold EA, Rebchook GM. Uptake, retention, and adherence to pre-exposure prophylaxis (PrEP) in TRIUMPH: A peer-led PrEP demonstration project for transgender communities in Oakland and Sacramento, California. J Acquir Immune Defic Syndr. 2021;88(1):S27.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4810_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/109019817400200405","volume":"2","author":"IM Rosenstock","year":"1974","unstructured":"Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354\u201386.","journal-title":"Health Educ Monogr"},{"issue":"4","key":"4810_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/109019817400200407","volume":"2","author":"MH Becker","year":"1974","unstructured":"Becker MH. The health belief model and sick role behavior. Health Educ Monogr. 1974;2(4):409\u201319.","journal-title":"Health Educ Monogr"},{"issue":"10","key":"4810_CR23","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s10461-019-02502-y","volume":"23","author":"S Wood","year":"2019","unstructured":"Wood S, Gross R, Shea JA, Bauermeister JA, Franklin S, Petsis D, Dowshen N. Barriers and facilitators of PrEP adherence for young men and transgender women of color. AIDS Behav. 2019;23(10):2719\u201329.","journal-title":"AIDS Behav"},{"key":"4810_CR24","volume-title":"Motivational interviewing: helping people change","author":"WR Miller","year":"2013","unstructured":"Miller WR, Rollnick S. Motivational interviewing: helping people change. 3rd ed. New York: Guilford Press; 2013.","edition":"3"},{"issue":"8","key":"4810_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1037\/adb0000318","volume":"31","author":"CC DiClemente","year":"2017","unstructured":"DiClemente CC, Corno CM, Graydon MM, Wiprovnick AE, Knoblach DJ. Motivational interviewing, enhancement, and brief interventions over the last decade: a review of reviews of efficacy and effectiveness. Psychol Addict Behav. 2017;31(8):862\u201387.","journal-title":"Psychol Addict Behav"},{"issue":"4","key":"4810_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.pec.2016.10.029","volume":"100","author":"PK Dillard","year":"2017","unstructured":"Dillard PK, Zuniga JA, Holstad MM. An integrative review of the efficacy of motivational interviewing in HIV management. Patient Educ Couns. 2017;100(4):636\u201346.","journal-title":"Patient Educ Couns"},{"issue":"2","key":"4810_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pec.2013.07.012","volume":"93","author":"B Lundahl","year":"2013","unstructured":"Lundahl B, Moleni T, Burke BL, Butters R, Tollefson D, Butler C, Rollnick S. Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Educ Couns. 2013;93(2):157\u201368.","journal-title":"Patient Educ Couns"},{"issue":"7","key":"4810_CR28","first-page":"109","volume":"118","author":"G Bischof","year":"2021","unstructured":"Bischof G, Bischof A, Rumpf HJ. Motivational interviewing: an evidence-based approach for use in medical practice. Dtsch Arztebl Int. 2021;118(7):109\u201315.","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"4810_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11606-016-3685-3","volume":"31","author":"A Palacio","year":"2016","unstructured":"Palacio A, Garay D, Langer B, Taylor J, Wood BA. Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med. 2016;31(8):929\u201340.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"4810_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAI.0000000000003091","volume":"91","author":"SR Morris","year":"2022","unstructured":"Morris SR, Letourneau D, Safer M, O\u2019Keefe C, Weibel N, Liu L, Moore DJ. Randomized trial of individualized texting for adherence building (iTAB) plus motivational interviewing for PrEP adherence in transgender individuals: The iM-PrEPT Study. J Acquir Immune Defic Syndr. 2022;91(5):453\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4810_CR31","unstructured":"HIVinfo.: Pre-Exposure Prophylaxis (PrEP) Fact Sheet. 2025. https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/pre-exposure-prophylaxis-prep."},{"issue":"3","key":"4810_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000002354","volume":"84","author":"J Yager","year":"2020","unstructured":"Yager J, Castillo-Mancilla JR, Ibrahim ME, Glynn J, Ritchie JC, Liu AY, Anderson PL. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: The TAF-DBS Study. J Acquir Immune Defic Syndr. 2020;84(3):323\u201330.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4810_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","volume":"122","author":"J-H Zheng","year":"2016","unstructured":"Zheng J-H, Rower C, McAllister K, Castillo-Mancilla J, Meditz A, Gardner E, Anderson P. Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. J Pharmaceut Biomed Anal. 2016;122:16\u201320.","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"4","key":"4810_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/1073191107304295","volume":"14","author":"L Balfour","year":"2007","unstructured":"Balfour L, Kowal J, Silverman A, Tasca GA, Angel JB, Macpherson PA, Garber G. Development and validation of the HIV medication readiness scale. Assessment. 2007;14(4):408\u201316.","journal-title":"Assessment"},{"issue":"9","key":"4810_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"4810_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1348\/135910705X53155","volume":"11","author":"MA Chesney","year":"2006","unstructured":"Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S. A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol. 2006;11(3):421\u201337.","journal-title":"Br J Health Psychol"},{"issue":"4","key":"4810_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385\u201396.","journal-title":"J Health Soc Behav"},{"issue":"2","key":"4810_CR38","doi-asserted-by":"publisher","first-page":"251524592210803","DOI":"10.1177\/25152459221080396","volume":"5","author":"M Maier","year":"2022","unstructured":"Maier M, Lakens D. Justify your alpha: a primer on two practical approaches. Adv Methods Pract Psychol Sci. 2022;5(2):25152459221080396.","journal-title":"Adv Methods Pract Psychol Sci"},{"issue":"1","key":"4810_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.11157\/fohpe.v23i1.544","volume":"23","author":"DF Vears","year":"2022","unstructured":"Vears DF, Gillam L. Inductive content analysis: a guide for beginning qualitative researchers. Focus Health Professional Educ Multi-Professional J. 2022;23(1):111\u201325.","journal-title":"Focus Health Professional Educ Multi-Professional J"},{"issue":"21","key":"4810_CR40","doi-asserted-by":"publisher","first-page":"11332","DOI":"10.3390\/ijerph182111431","volume":"18","author":"SJ Miller","year":"2021","unstructured":"Miller SJ, Harrison SE, Sanasi-Bhola K. A scoping review investigating relationships between depression, anxiety, and the PrEP care continuum in the United States. Int J Environ Res Public Health. 2021;18(21):11332.","journal-title":"Int J Environ Res Public Health"},{"key":"4810_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10461-020-03004-y","volume":"25","author":"SM Wood","year":"2021","unstructured":"Wood SM, Lee S, Barg FK, Castillo M, Dowshen NL, Schneider JA. Mental health, social influences, and HIV pre-exposure prophylaxis (PrEP) utilization among men and transgender individuals screening for HIV prevention trials. AIDS Behav. 2021;25:524\u201331.","journal-title":"AIDS Behav"},{"key":"4810_CR42","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s10461-016-1415-9","volume":"20","author":"ML Mehrotra","year":"2016","unstructured":"Mehrotra ML, Westreich D, McMahan VM, Amico KR, Hendrix CW, Pettifor A, Liu AY. The effect of depressive symptoms on adherence to daily oral PrEP in men who have sex with men and transgender women: a marginal structural model analysis of the iPrEx OLE study. AIDS Behav. 2016;20:1527\u201334.","journal-title":"AIDS Behav"},{"issue":"4","key":"4810_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/apc.2012.0419","volume":"27","author":"SA Golub","year":"2013","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger C. From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248\u201354.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"4810_CR44","first-page":"1409","volume":"71","author":"M Ashraf","year":"2021","unstructured":"Ashraf M, Virk RN. Determinants of medication adherence in patients with HIV: application of the health belief model. J Pak Med Assoc. 2021;71(5):1409\u201312.","journal-title":"J Pak Med Assoc"},{"issue":"5","key":"4810_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1521\/aeap.2020.32.5.416","volume":"32","author":"SZ Ching","year":"2020","unstructured":"Ching SZ, Yee A, Ramachandran V, Sulaiman AH, Haque M. Meta-synthesis of qualitative research of pre-exposure prophylaxis (PrEP) adherence among men who have sex with men (MSM). AIDS Educ Prev. 2020;32(5):416\u201331.","journal-title":"AIDS Educ Prev"},{"issue":"11","key":"4810_CR46","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/09540121.2022.2098908","volume":"34","author":"RJ Watson","year":"2022","unstructured":"Watson RJ, Wheldon CW, Glick JL, Chard A, Wilson PA, Galvez A. PrEP stigma and logistical barriers remain significant challenges in curtailing HIV transmission among Black and Hispanic\/Latinx cisgender sexual minority men and transgender women in the US. AIDS Care. 2022;34(11):1465\u201372.","journal-title":"AIDS Care"},{"issue":"5","key":"4810_CR47","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s10461-017-1690-0","volume":"21","author":"LA Eaton","year":"2017","unstructured":"Eaton LA, Driffin DD, Bauermeister J, Smith H, Conway-Washington C. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236\u201346.","journal-title":"AIDS Behav"},{"issue":"5","key":"4810_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/09564624231152781","volume":"34","author":"F Teng","year":"2023","unstructured":"Teng F, Gautam A, Biello K, Oldenburg CE, Mitchell J. Barriers to uptake of PrEP across the continuum among transgender women: a global scoping review. Int J STD AIDS. 2023;34(5):299\u2013314.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"4810_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11121-019-0985-y","volume":"20","author":"C Grov","year":"2019","unstructured":"Grov C, Westmoreland DA, Rendina HJ, Nash D, Parsons JT. Gay and bisexual men\u2019s strategies to maintain daily adherence to their HIV pre-exposure prophylaxis (PrEP) medication: results from a qualitative study. Prev Sci. 2019;20(1):168\u201377.","journal-title":"Prev Sci"},{"issue":"6","key":"4810_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/apc.2021.0236","volume":"36","author":"M Dang","year":"2022","unstructured":"Dang M, Loe M, Hull SJ, Korpak AK. Barriers and facilitators to HIV pre-exposure prophylaxis uptake, adherence, and persistence among transgender populations in the United States: a systematic review. AIDS Patient Care STDS. 2022;36(6):236\u201348.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"4810_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/09540121.2020.1769835","volume":"33","author":"O Nieto","year":"2021","unstructured":"Nieto O, Huang Y, Perotte R, Martinez M. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users. AIDS Care. 2021;33(2):244\u201352.","journal-title":"AIDS Care"},{"issue":"151","key":"4810_CR52","doi-asserted-by":"publisher","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","volume":"4","author":"PL Anderson","year":"2012","unstructured":"Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, Grant RM. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.","journal-title":"Sci Transl Med"},{"issue":"12","key":"4810_CR53","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1080\/09540121.2020.1757021","volume":"32","author":"C Owens","year":"2020","unstructured":"Owens C, Hubach R, Lester C, Reece M. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM). AIDS Care. 2020;32(12):1581\u20138.","journal-title":"AIDS Care"},{"issue":"6","key":"4810_CR54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1521\/aeap.2020.32.6.472","volume":"32","author":"CW-M Watson","year":"2020","unstructured":"Watson CW-M, Wheldon C, Faulkenberry L, Glick J, Brawner BM. Barriers and facilitators to PrEP initiation and adherence among transgender and gender non-binary individuals in Southern California. AIDS Educ Prev. 2020;32(6):472\u201385.","journal-title":"AIDS Educ Prev"},{"issue":"11","key":"4810_CR55","first-page":"1378","volume":"28","author":"MA Kesler","year":"2016","unstructured":"Kesler MA, Kaul R, Myers T, Liu J, Loutfy MR. Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto. Canada AIDS Care. 2016;28(11):1378\u201385.","journal-title":"Canada AIDS Care"},{"issue":"5","key":"4810_CR56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/apc.2018.0289","volume":"33","author":"J Blumenthal","year":"2019","unstructured":"Blumenthal J, Jain S, Mulvihill E, Sun X, Hanashiro M, Ellorin E, Morris SR. Recent HIV risk behavior and partnership type predict HIV pre-exposure prophylaxis adherence in men who have sex with men. AIDS Patient Care STDs. 2019;33(5):220\u20136.","journal-title":"AIDS Patient Care STDs"},{"key":"4810_CR57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1017\/cts.2023.636","volume":"7","author":"J Warus","year":"2023","unstructured":"Warus J, Wong C, Olson-Kennedy J. Relationships between self-perceived risk of HIV, behavioral risk of HIV, and self-reported pre-exposure prophylaxis (PrEP) utilization among young men who have sex with men of color at risk for HIV infection: findings from a prospective cohort study. J Clin Transl Sci. 2023;7:216.","journal-title":"J Clin Transl Sci"},{"issue":"8","key":"4810_CR58","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/OLQ.0000000000000472","volume":"43","author":"JJ Carroll","year":"2016","unstructured":"Carroll JJ, Campbell LM, Mugo NR, Ngure K, Heffron R, Baeten JM. Perceived risk among human immunodeficiency virus serodiscordant couples in East Africa taking oral pre-exposure prophylaxis. Sex Transm Dis. 2016;43(8):471\u20135.","journal-title":"Sex Transm Dis"},{"issue":"7","key":"4810_CR59","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10508-017-1100-8","volume":"47","author":"K Underhill","year":"2018","unstructured":"Underhill K, Morrow KM, Colleran C, Holcomb R, Calabrese SK, Operario D, Mayer KH. Temporal fluctuations in behavior, perceived HIV risk, and willingness to use pre-exposure prophylaxis (PrEP). Arch Sex Behav. 2018;47(7):2109\u201321.","journal-title":"Arch Sex Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04810-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:12:41Z","timestamp":1759839161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04810-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4810"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04810-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"15 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}